Ophthalmology · Boise, ID
NPI
1578657094
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
999 N. Curtis, Suite 205
Boise, ID, 83706
Phone (208) 373-1200
Medicare paid, 2024
$103K
1,530 services
Medicare patients, 2024
1,007
Average age 76
Drug cost, 2024
$153K
1,447 prescriptions
Company payments, 2025
$119
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathryn M Fethke was code 92014 (ophthalmological e&m), 900 times for 899 patients. In total Kathryn M Fethke billed 1,530 services in 26 codes, and Medicare paid $103K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 900 | 899 | $73.78 | $66K |
| 99213 Office E&M - Established | Office | 168 | 151 | $56.41 | $9,478 |
| 92134 Computerized Ophthalmic Imaging | Office | 141 | 140 | $25.18 | $3,551 |
| 92083 Vision, Hearing, and Speech Services | Office | 83 | 83 | $40.75 | $3,382 |
| 92004 Ophthalmological E&M | Office | 56 | 56 | $74.91 | $4,195 |
| 92133 Computerized Ophthalmic Imaging | Office | 48 | 48 | $20.99 | $1,007 |
| 66821 Cataract Surgery | Facility | 33 | 33 | $255.04 | $8,416 |
| 99212 Office E&M - Established | Office | 27 | 23 | $29.81 | $805 |
| 99214 Office E&M - Established | Office | 19 | 18 | $74.22 | $1,410 |
| 92012 Ophthalmological E&M | Office | 13 | 13 | $50.16 | $652 |
By year: 2022 $124K for 1,654 services; 2023 $111K for 1,622 services; 2024 $103K for 1,530 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathryn M Fethke prescribed most often to Medicare patients was Latanoprost, with 570 prescriptions and refills. In total Kathryn M Fethke wrote 1,447 Medicare prescriptions that cost $153K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 570 | 1,341 | 159 | $5,491 |
| Timolol Maleate Generic | 173 | 456 | 52 | $1,072 |
| Erythromycin Erythromycin Base | 103 | 105 | 75 | $1,001 |
| Restasis Cyclosporine | 85 | 126 | 39 | $79K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 71 | 74 | 54 | $900 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 71 | 150 | 19 | $524 |
| Prednisolone Acetate Generic | 39 | 56 | 23 | $1,033 |
| Brimonidine Tartrate Generic | 35 | 82 | 14 | $324 |
| Loteprednol Etabonate Generic | 31 | 47 | 22 | $5,075 |
| Apraclonidine Hcl Generic | 29 | 41 | 11 | $1,475 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 29 | 63 | Under 11 | $2,312 |
| Ketorolac Tromethamine Generic | 23 | 27 | Under 11 | $923 |
| Cyclosporine Generic | 20 | 40 | 12 | $11K |
| Xiidra Lifitegrast | 18 | 22 | Under 11 | $15K |
| Lumigan Bimatoprost | 15 | 25 | Under 11 | $7,862 |
Brand drugs: 608 claims; generic drugs: 839 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathryn M Fethke $119 ($119 in general payments such as food, travel and fees) from 2 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $104.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.